CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Abbvie Inc v. Medimmune Limited

2:16-cv-00322

Overview

Case Number 2:16-cv-00322
Filing Date 2016-06-22
Status Terminated
Termination Date 2017-01-26
Court District Court, E.D. Virginia (vaed)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:1 Patent Non-Infringement - Declaratory Judgment
Jury Demand None

Parties

Defendant

Medimmune Limited NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Abbvie Biotechnology Ltd. Operating Company

Represented By

1 Attorneys Listed

Matthew Donald Aichele

Latham & Watkins LLP (DC)

Tel: +1 (202) 637-1060

555 11th St NW, Suite 1000

Abbvie Inc Operating Company

Represented By

1 Attorneys Listed

Matthew Donald Aichele

Latham & Watkins LLP (DC)

Tel: +1 (202) 637-1060

555 11th St NW, Suite 1000

Court & Judges

Court

District Court, E.D. Virginia (vaed)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6248516
Single domain ligands, receptors comprising said ligands methods for their production, and use of said ligands and receptors
Filed: 1995-06-06
Issued: 2001-06-19
Expired (Term Ended)
Expires: 2015-06-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

5

Dispositive

1

Granted

0

Denied

0

Pending / Review

5

Motions by Category

Procedural / Extension Motion 4 Motion to Dismiss 1

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
Motion to Dismiss
Entry #13 • 2016-08-25 Document →
Procedural / Extension Motion Pending / Under Review
Order on Motion for Leave to File
Entry #38 • 2017-01-26 Document →
Procedural / Extension Motion Pending / Under Review
Motion for Leave to File
Entry #35 • 2016-09-15 Document →
Procedural / Extension Motion Pending / Under Review
Order on Motion for Extension of Time to File
Entry #11 • 2016-07-26 Document →
Procedural / Extension Motion Pending / Under Review
Motion for Extension
Entry #10 • 2016-07-22 Document →

Docket Entries

(59 total)
Pleading / Complaint

COMPLAINT against Medimmune Limited ( Filing fee $ 400, receipt number 14683059898.), filed by Abbvie Inc, Abbvie Biotechnology Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Civil Cover Sheet, # 12 Receipt)(epri) (Entered: 06/24/2016)

Entry #1 • 2016-06-22
1
Pleading / Complaint

COMPLAINT against Medimmune Limited ( Filing fee $ 400, receipt number 14683059898.), filed by Abbvie Inc, Abbvie Biotechnology Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Civil Cover Sheet, # 12 Receipt)(epri) (Entered: 06/24/2016)

Entry #1 • 2016-06-22
2
Pleading / Complaint

COMPLAINT against Medimmune Limited ( Filing fee $ 400, receipt number 14683059898.), filed by Abbvie Inc, Abbvie Biotechnology Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Civil Cover Sheet, # 12 Receipt)(epri) (Entered: 06/24/2016)

Entry #1 • 2016-06-22
2
Pleading / Complaint

COMPLAINT against Medimmune Limited ( Filing fee $ 400, receipt number 14683059898.), filed by Abbvie Inc, Abbvie Biotechnology Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Civil Cover Sheet, # 12 Receipt)(epri) (Entered: 06/24/2016)

Entry #1 • 2016-06-22
2
Pleading / Complaint

COMPLAINT against Medimmune Limited ( Filing fee $ 400, receipt number 14683059898.), filed by Abbvie Inc, Abbvie Biotechnology Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Civil Cover Sheet, # 12 Receipt)(epri) (Entered: 06/24/2016)

Entry #1 • 2016-06-22
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc